New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Kronos Bio, Inc.
KRON
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

57M

Biotechnology

Next Earning date - 11 Nov 2024

57M

Biotechnology

Next Earning date - 11 Nov 2024

0.95USD
Shape0.02 ( 2.15%)
favorite-chart

Relative Strenght

9
favorite-chart

Volume Buzz

-78%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

41%

Quote Panel

Shape
Updated October 19, 2024
1W 3.26 % 1M -7.77 % 3M -24.00 % 1Y 4.97 %

Key Metrics

Shape
  • Market Cap

    57.28M


  • Shares Outstanding

    60.29M


  • Share in Float

    39.46M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    0.95


  • Average Volume

    91596


  • Beta

    1.878


  • Range

    0.69-1.6


  • Industry

    Biotechnology


  • Website

    https://kronosbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

6.81x

P/S Ratio

0.46x

P/B Ratio

0.2

Debt/Equity

-1222.8%

Net Margin

$-1.7

EPS

How KRON compares to sector?

P/E Ratio

Relative Strength

Shape

KRON

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3M

Shape28%

2025-Revenue

$1.39

Shape-413%

2025-EPS

$2M

Shape112%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.57
vs -0.61

Q4.22

arrow
arrow

N/A

-0.56
vs -1.13

Q1.23

arrow
arrow

N/A

-0.46
vs -0.65

Q2.23

arrow
arrow

N/A

-0.52
vs -0.59

Q3.23

arrow
arrow

N/A

-0.54
vs -0.57

Q4.23

arrow
arrow

N/A

-0.43
vs -0.56

Q1.24

arrow
arrow

N/A

-0.50
vs -0.46

Q2.24

arrow
arrow

N/A

-0.27
vs -0.52

Q3.24

arrow
arrow

N/A

-0.28
vs -0.54

Q4.24

arrow
arrow

N/A

-0.30
vs -0.43

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

1.2M  vs NA

Q2.23

arrow
arrow

NA

1.9M  vs NA

Q3.23

arrow
arrow

NA

917K  vs NA

Q4.23

arrow
arrow

NA

2.3M  vs NA

Q1.24

arrow
arrow

+106%

2.5M  vs 1.2M

Q2.24

arrow
arrow

+44%

2.7M  vs 1.9M

Q3.24

arrow
arrow

+129%

2.1M  vs 917K

Q4.24

arrow
arrow

-8%

2.1M  vs 2.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-12%

-0.12
vs -0.11

Q4.22

arrow
arrow

-12%

-0.12
vs -0.12

Q1.23

arrow
arrow

-10%

-0.10
vs -0.12

Q2.23

arrow
arrow

-15%

-0.15
vs -0.10

Q3.23

arrow
arrow

-18%

-0.18
vs -0.15

Q4.23

arrow
arrow

-16%

-0.16
vs -0.18

Q1.24

arrow
arrow

-22%

-0.22
vs -0.16

Q2.24

arrow
arrow

-13%

-0.13
vs -0.22

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

93

93
vs 95

-2%

Q4.22

arrow
arrow

98

98
vs 93

5%

Q1.23

arrow
arrow

88

88
vs 98

-10%

Q2.23

arrow
arrow

81

81
vs 88

-8%

Q3.23

arrow
arrow

64

64
vs 81

-21%

Q4.23

arrow
arrow

59

59
vs 64

-8%

Q1.24

arrow
arrow

58

58
vs 59

-2%

Q2.24

arrow
arrow

56

56
vs 58

-3%

Earnings Growth

Latest News